Description
The investment climate for firms producing genetically modified (GM) agricultural products has recently experienced considerable change, with the occurrence of remarkably high rate of farmer acceptance, but considerable consumer resistance. The present system that involves firms developing biotech products, farmers producing the products, food and related agribusiness industrial firms, and consumers of food, is very volatile. This however will soon be affected by changes in reulatory, trade and food safety regimes.This book addresses these key issues and is based on papers presented at the fourth meeting of The International Consortium on Agricultural Biotechnology Research (ICABR), on Economics of Agricultural Biotechnology, held at Ravello, Italy, in August 2000. Organized in four parts, this volume focuses on:Consumer reactions to GM food informationRegulatory issuesFarmer acceptance of biotech productsChanges in industrial organization in life science and food sectors
Chapter
1 A Way Forward for Frankenstein Foods
2 A Comparison of Consumer Attitudes towards GM Food in Ireland and the United States: a Case Study Over Time1
3 Differences in Public Acceptance between Generic and Premium Branded GM Food Products: an Analytical Model
4 Is European Consumers’ Refusal of GM Food a Serious Obstacle or a Transient Fashion?
5 Estimates of Willingness to Pay a Premium for Non-GM Foods: a Survey
6 A Consumer-based Approach towards New Product Development through Biotechnology in the Agro-food Sector
7 The Impact of Bovine Somatotropin on Farm Profits
8 The Importance of Feed Management Technologies in the Decision to Adopt Bovine Somatotropin: an Application to California Dairy Producers
9 The Potential Effect of Recombinant Bovine Somatotropin on World Dairying
10 Gains to Yield-increasing Research in the Evolving Canadian Canola Research Industry
11 Determinants of GMO Use: a Survey of Iowa Maize–Soybean Farmers’ Acreage Allocation1
12 Estimating Adoption of GMO Soybeans and Maize: a Case Study of Ohio, USA
13 Ex ante Economic Assessment of Adopting Genetically Engineered Crops in Finland
14 Biotechnology, Farm Management and Local Agricultural Development1
15 Public Acceptance of and Benefits from Agricultural Biotechnology: a Key Role for Verifiable Information
16 Science and Regulation: Assessing the Impacts of Incomplete Institutions and Information in the Global Agricultural Biotechnology Industry
17 Quantifying Scientific Risk Communications of Agrobiotechnology
18 Time Series Analysis of Risk Frames in Media Communication of Agrobiotechnology
19 Case Study in Benefits and Risks of Agricultural Biotechnology: Roundup Ready Soybeans
20 Labelling for GM Foods: Theory and Practice
21 Estimating the Costs of Segregation for Non-biotech Maize and Soybeans
22 Endogenous Demand and Optimal Product Regulation: the Case of Agricultural Biotechnology
23 Tobin’s q and the Value of Agriceutical Firms
24 The Structure of the European Agro-food Biotechnology Industry: Are Strategic Alliances Here to Stay?
25 Market Structure in Biotechnology: Implications for Long-run Comparative Advantage
26 Biotechnology in the Supply Chain: Managing a Product Differentiating Technology